Skip to Main Content

Close

Journals
Professional Books
ADA Standards of Care
ADA Meeting Abstracts
Clinical Compendia
Podcasts
Professional News

header search

search input Search input auto suggest

filter your search

Search

Advanced Search

Menu

Current
Browse
Info & About
Podcasts
Subscriptions
Alerts
Submit
- Submit a Manuscript
- Submit a Cover Image

Skip Nav Destination

Article navigation

Volume 46, Issue 9

1 September 1997

Previous Article
Next Article

SI Units Table| September 01 1997

Table 1—Système International (SI) units for plasma, serum, or blood concentrations

Diabetes 1997;46(9):1533

https://doi.org/10.2337/diab.46.9.1533

Split-Screen
Views
Open the PDF for in another window
Share
- Facebook
- Twitter
- LinkedIn
- Email
Cite
Get Permissions

Citation

Table 1—Système International (SI) units for plasma, serum, or blood concentrations. Diabetes 1 September 1997; 46 (9): 1533. https://doi.org/10.2337/diab.46.9.1533

Download citation file:

Ris (Zotero)
Reference Manager
EasyBib
Bookends
Mendeley
Papers
EndNote
RefWorks
BibTex

toolbar search

toolbar search

search input Search input auto suggest

filter your search

Search

Advanced Search

This content is only available via PDF.

Copyright © 1997 by the American Diabetes Association

1997

Article PDF first page preview

Article PDF first page preview

Article PDF first page preview

15 Views

View Metrics

×

Email alerts

Article Activity Alert

Online Ahead of Print Alert

Latest Issue Alert

Most Read
Most Cited

MRI Metrics of Cerebral Endothelial Cell–Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel

713-P: Is There a Correct Time to Measure Fasting Blood Sugar in Persons with Type 2 Diabetes Melitus?

Elevated First-Trimester Neutrophil Count Is Closely Associated With the Development of Maternal Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes

300-OR: Beneficial Effect of the Combination Therapy of Cagrilintide, a Dual Amylin/Calcitonin Agonist, and Tirzepatide, a Dual GLP-1/GIP Agonist, on Body Weight Loss in Obese Rats

Online ISSN 1939-327X
Print ISSN 0012-1797

Journals

Diabetes
Diabetes Care
Clinical Diabetes
Diabetes Spectrum
Standards of Medical Care in Diabetes
Scientific Sessions Abstracts
BMJ Open Diabetes Research & Care

Books

ShopDiabetes.org
ADA Professional Books

Clinical Compendia

Clinical Compendia Home

News

Latest News
DiabetesPro SmartBrief

Other

Special Collections
DiabetesPro®
Diabetes Food Hub™
Insulin Affordability
Know Diabetes By Heart™

About

About the ADA
Journal Policies
For Reviewers
Advertising in ADA Journals
Reprints and Permission for Reuse
Copyright Notice/Public Access Policy

Resources

ADA Professional Membership
ADA Member Directory
Diabetes.org

X (Twitter)
Facebook
LinkedIn

Contact Us
Cookie Policy
Accessibility
Terms & Conditions
Get Adobe Acrobat Reader
© Copyright American Diabetes Association

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept